Patients with a history of medullary thyroid carcinoma or MEN 2 syndrome should not use any GLP-1 receptor agonist
For tirzepatide users, dietary guidance for tirzepatide covers the same ground with medication-specific considerations
By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future
Because retatrutide remains investigational, I recommend that patients discuss potential side effects with a qualified medical professional and avoid using products marketed outside legitimate clinical trial settings
As a sophisticated triple-agonist peptide with CAS number 2381089-83-2 and molecular weight of 4731.20, Retatrutide Powder from Shaanxi Hongda Phytochemistry Co., Ltd
HDL cholesterol modestly increased across the dose range, while LDL cholesterol showed minimal change a pattern consistent with weight-mediated lipid improvements rather than direct drug effects on LDL pathways
